BioLife Solutions
BLFS
15 hedge funds and large institutions have $813K invested in BioLife Solutions in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
46% more capital invested
Capital invested by funds: $558K → $813K (+$255K)
0.55% more ownership
Funds ownership: 2.06% → 2.61% (+0.55%)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$218K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.05K |
| 3 |
BlackRock
New York
|
+$1.1K |
| 4 |
Morgan Stanley
New York
|
+$33 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$60K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$637 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$446 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSA
1
Schonfeld Strategic Advisors
New York
| $239K | +$218K | +100,000 | New |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $232K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $165K | – | – | – |
|
|
4
BlackRock
New York
| $88K | +$1.1K | +508 | +1% |
|
|
5
T. Rowe Price Associates
Baltimore,
Maryland
| $40K | +$3.05K | +1,400 | +9% |
|
|
PCM
6
Perkins Capital Management
Wayzata,
Minnesota
| $24K | – | – | – |
|
7
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $24K | – | – | – |
|
|
CB
8
Community Bank
Dewitt,
New York
| $1K | – | – | – |
|
|
VKH
9
Virtu KCG Holdings
New York
| – | -$60K | -28,864 | Closed |
|
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$637 | -293 | -100% |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$446 | -205 | -60% |
|
|
12
Morgan Stanley
New York
| – | +$33 | +15 | New |
|
BLFS Hedge Fund Activity: Q2 2017 in Review
15 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2017, worth a combined $813K — up 46% from $558K a quarter earlier.
Fund positioning in BLFS was balanced in Q2 2017: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $218K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $60K sold.
- 15 institutional investors held BioLife Solutions (BLFS) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $813K of BioLife Solutions stock for Q2 2017, up 46% quarter-over-quarter.
- 2 funds opened new BioLife Solutions positions in Q2 2017 and 2 closed out, a net change of 0 holders.
- The largest BioLife Solutions buyer in Q2 2017 was Schonfeld Strategic Advisors, an estimated $218K added.
- The largest BioLife Solutions seller in Q2 2017 was Virtu KCG Holdings, an estimated $60K sold.
Based on aggregated 13F filings for Q2 2017.